Parkinson's Disease Grants in Australia: Funding Research and Support

Parkinson's disease affects approximately 100,000 Australians — and incidence is rising as the population ages. A progressive neurological condition affecting movement, cognition, and many non-motor functions, Parkinson's is the second most common neurodegenerative disease after Alzheimer's. There is no cure, but treatment has improved significantly, and exercise has emerged as one of the most powerful interventions. Grant funding supports research into better treatments and ultimately a cure, as well as the community services and exercise programmes that help people with Parkinson's live well.

Parkinson's disease in Australia

Scale

  • Approximately 100,000 Australians live with Parkinson's
  • New diagnoses: approximately 38 people per day
  • Most commonly diagnosed after 60, but approximately 12-15% are diagnosed under 50 (Young Onset Parkinson's Disease — YOPD)
  • More common in men than women (approximately 60-40 ratio)
  • Incidence projected to double by 2050 with ageing population

Symptoms

Motor symptoms (the classic features):
- Tremor (resting tremor — often the most visible symptom)
- Rigidity (muscle stiffness)
- Bradykinesia (slowness of movement)
- Postural instability (balance impairment, falls risk)

Non-motor symptoms (often underrecognised and undertreated):
- Cognitive impairment and dementia (in later stages)
- Depression and anxiety
- Sleep disorders (REM behaviour disorder, insomnia)
- Autonomic dysfunction (blood pressure, constipation, urinary)
- Hyposmia (reduced sense of smell — often an early symptom)
- Fatigue
- Psychosis (particularly on dopaminergic medications)
- Pain

Disease course

Parkinson's is progressive — symptoms worsen over time. The rate of progression is highly variable. Most people live for many years with Parkinson's, often decades. Late-stage Parkinson's can be severely disabling.

Government Parkinson's funding

NHMRC

Research grants for Parkinson's neurobiology, biomarkers, and treatment.

Medical Research Future Fund (MRFF)

Translational research including deep brain stimulation, gene therapy, and precision medicine for Parkinson's.

NDIS

People with advanced Parkinson's may access NDIS support for daily living, equipment, and community access.

Aged Care

Many people with Parkinson's in aged care — CHSP and residential aged care funding.

PBS

Levodopa and other dopaminergic medications are PBS-listed; DBS devices are funded through hospital system.

Philanthropic Parkinson's funders

Parkinson's Australia

National peak body:
- Research grants programme
- Advocacy
- Information and resources
- State-based service delivery through member organisations

Parkinson's Victoria / NSW / QLD / WA / SA / TAS

State-based support organisations:
- Information and helplines
- Exercise programmes (Rock Steady Boxing, LSVT BIG, PWR!)
- Support groups
- Allied health

Shake It Up Australia Foundation

Dedicated Parkinson's research funder:
- Research grants
- Clinical trials support
- Advocacy for research investment

Foundation for Parkinson's Research

Research funding.

Michael J. Fox Foundation for Parkinson's Research

US-based global funder — some Australian research supported.

Types of funded Parkinson's programmes

Research

  • Neuroprotection (slowing or stopping disease progression — the biggest unmet need)
  • Alpha-synuclein aggregation (the protein that forms Lewy bodies)
  • LRRK2 and GBA mutations — specific genetic forms
  • Deep brain stimulation (DBS) optimisation and next-generation devices
  • Gene therapy (AAV-delivered gene therapies in trials)
  • Gut-brain axis (emerging research on gut microbiome in Parkinson's)
  • Biomarkers (early detection — diagnosis currently clinical, not biological)
  • Women and Parkinson's (sex differences underresearched)

Clinical trials

Australia participates in major international Parkinson's trials — access is important for patients.

Exercise programmes

Exercise is one of the most powerful interventions for Parkinson's — evidence for multiple modalities:
- Boxing for Parkinson's (Rock Steady Boxing, non-contact)
- LSVT BIG (amplitude-based physiotherapy)
- Dance for Parkinson's (improving balance, coordination, social connection)
- Cycling (forced-rate cycling has strong evidence)
- Tai chi (balance and fall prevention)
- Hydrotherapy
- Parkinson's-specific group exercise classes

Grant funding for exercise programmes is high-impact and well-aligned with evidence.

Allied health services

  • Speech pathology (voice — LSVT LOUD; swallowing)
  • Occupational therapy (home safety, adaptive equipment, driving)
  • Physiotherapy (movement, falls prevention)
  • Neuropsychology
  • Social work

Deep brain stimulation (DBS)

  • DBS is highly effective for motor symptoms in eligible patients
  • Access is inequitable — more available in major cities
  • DBS programming support
  • Rural and remote DBS access (remote programming is emerging)

Young Onset Parkinson's (YOPD)

Parkinson's diagnosed under 50 has different implications:
- Employment impacts (most YOPD patients are still working)
- Family impacts (young children, relationship strain)
- Long disease course ahead
- Different medication management considerations (avoid excessive levodopa early)
- Specific support needs (peer groups for younger people)

Carer support

Caring for someone with advancing Parkinson's is demanding:
- Carer education
- Respite
- Peer support for carers
- End-of-life care preparation

Dementia and Parkinson's

Cognitive impairment occurs in many people with Parkinson's over time:
- Cognitive rehabilitation
- Dementia care integration
- Behavioural support

End-of-life care

Advanced Parkinson's requires specialist palliative care:
- Symptom management (dyskinesia, dysphagia, psychosis)
- Advance care planning
- Hospice access for Parkinson's patients

Grant application considerations

Exercise: the evidence-based imperative

Exercise has stronger evidence for Parkinson's than most pharmaceutical interventions for non-motor symptom management and quality of life. Community exercise programmes (boxing, dance, cycling) are high-impact, cost-effective, and community-building.

YOPD: the underserved subgroup

Young Onset Parkinson's patients have dramatically different needs from typical older-onset patients. Employment, family, and long disease course are the defining challenges — specialist YOPD programmes are underserved.

Rural and remote access

Specialist neurology and allied health is concentrated in major cities. Telehealth for Parkinson's (remote physiotherapy, DBS programming, clinical review) is an expanding and underserved area.

Neuroprotection: the research frontier

No neuroprotective therapy currently exists for Parkinson's — it's the highest-priority research question. Applications contributing to this search are well-positioned with research funders.


Tahua's grants management platform supports neurological disease funders and Parkinson's organisations — with programme participant tracking, exercise outcome measurement, research grant administration, and the reporting tools that help Parkinson's funders demonstrate their investment in better lives for Australians living with Parkinson's disease.

Book a conversation with the Tahua team →